Dry Eye disease

View All

Artificial Tears Market Analysis
Exploring the Growing Demand and Evolving Market Dynamics of Artificial Tears

The landscape of technology has indelibly reshaped various industries, and the healthcare sector stands as a prime beneficiary, especially evident in the profound innovation and intense development seen in the Artificial Tears Market in recent years. The advancements in nanotechnology, biotechnology, and material s...

Find More

Pharma News and Updates for Leo Pharma, GSK, Roche, Aldeyra, IASO Bio
Leo Pharma’s Hand Eczema Clinical Trial Updates; GSK’s PD-1 inhibitor Jemperli Approval; Roche Announces Phase III Result of Vabysmo; FDA Accepts NDA for Aldeyra’s reproxalap; RMAT and Fast Track Designations to IASO Bio’s CT103A; Orphan Drug Designation to Jubilant Therapeutics’s JBI-778

Leo Pharma Announces Positive Results of Phase III Hand Eczema Clinical Trial LEO Pharma A/S, a global leader in medical dermatology, announced that the DELTA 2 trial yielded positive results. DELTA 2 is the second of two pivotal phase III clinical trials involving delgocitinib cream, an investigational topical ...

Find More

Pharma News for Aktis, Alcon and Takeda
Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

Aktis Oncology Raises USD 84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals Aktis Oncology has raised an additional USD 84 million in its Series A round, adding to the USD 72 million raised last year to help bring its radiopharmaceuticals to market. The extension to the first round included Merck's...

Find More

medtech-news-for-cerner-scanwell-zynex-envista-sight-sciences
Cerner, Scanwell Health and Personal Genome Diagnostics Acquisition; Zynex’s Fluid Monitoring System, CM-1500; Sight Sciences’ TearCare System; Envista’s Nobel Biocare N1 Implant System

Oracle Corporation sets to acquire Cerner Corporation  On December 20, 2021, Oracle Corporation and Cerner Corporation entered into an agreement as per which Oracle will acquire Cerner through an all-cash tender offer for approximately USD 28.3 billion in equity value.  Larry Ellison, Chairman and C...

Find More